FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

20575311000001108: Sumatriptan 50mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69237701000001119 Sumatriptan 50mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69237801000001111 Sumatriptan 50mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sumatriptan 50mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Is a Product containing precisely sumatriptan (as sumatriptan succinate) 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has active ingredient Sumatriptan succinate false Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has specific active ingredient Sumatriptan succinate true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Pfizer Ltd) Has basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sumatriptan 50mg tablets (Pfizer Ltd) 6 tablet Has AMP True Sumatriptan 50mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start